Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Biomolecules
|
October 23, 2021
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
Erika Rimondi, Erica Valencic, Alberto Tommasini, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
Journal of Cellular Physiology
|
October 26, 2005
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation
Erika Rimondi, Paola Secchiero, Andrea Quaroni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 27, 2007
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway
Giorgio Zauli, Erika Rimondi, Federica Corallini, et al.
Hematological Oncology
|
September 6, 2019
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances
Carolina Simioni, Fabio Bergamini, Martina Ferioli, et al.
Investigational New Drugs
|
December 3, 2010
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL
Arianna Gonelli, Oriano Radillo, Sara Drioli, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?
Annalisa Marcuzzi, Erika Rimondi, Elisabetta Melloni, et al.
Frontiers in Medicine
|
November 17, 2022
The role of the mTOR pathway in diabetic retinopathy
Fabio Casciano, Enrico Zauli, Erika Rimondi, et al.
Life Science Alliance
|
March 6, 2023
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
Domenica Squillaci, Annalisa Marcuzzi, Erika Rimondi, et al.
Neoplasia (New York, N.Y.)
|
December 13, 2003
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release
Giorgio Zauli, Daniela Milani, Erika Rimondi, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Biomolecules
|
October 23, 2021
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
Erika Rimondi, Erica Valencic, Alberto Tommasini, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
Journal of Cellular Physiology
|
October 26, 2005
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation
Erika Rimondi, Paola Secchiero, Andrea Quaroni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 27, 2007
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway
Giorgio Zauli, Erika Rimondi, Federica Corallini, et al.
Hematological Oncology
|
September 6, 2019
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances
Carolina Simioni, Fabio Bergamini, Martina Ferioli, et al.
Investigational New Drugs
|
December 3, 2010
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL
Arianna Gonelli, Oriano Radillo, Sara Drioli, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?
Annalisa Marcuzzi, Erika Rimondi, Elisabetta Melloni, et al.
Frontiers in Medicine
|
November 17, 2022
The role of the mTOR pathway in diabetic retinopathy
Fabio Casciano, Enrico Zauli, Erika Rimondi, et al.
Life Science Alliance
|
March 6, 2023
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
Domenica Squillaci, Annalisa Marcuzzi, Erika Rimondi, et al.
Neoplasia (New York, N.Y.)
|
December 13, 2003
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release
Giorgio Zauli, Daniela Milani, Erika Rimondi, et al.
Page
of 7